Skip to main content

ASTEC · Astec LifeSciences Limited · Financials

551.85 INR +14.85 (+2.77%) At close · Nov 13
Market Cap
12.30B INR
Shares
22.28M
Volume · Nov 13 105.35K Avg daily vol (3M) 244.33K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
4.48B +17.5%
FY2026 Revenue FY2018–FY2026
Net Income
-809.18M +40%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
-807.08M -861%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
INR 4.39B 4.48B 3.81B 4.58B 6.28B 6.77B 5.55B 5.23B 4.31B 3.71B
INR 452.38M 449.22M 437.15M 362.53M 336.53M 343.56M 256.55M 231.64M 193.49M 146.82M
INR 298.9M 345.29M 366.97M 252.26M 207.14M 90.58M 47.51M 125.94M 123.76M 106.6M
INR -797.41M -810M -1.41B -617.48M 349.47M 1.21B 890.71M 613.53M 559.04M 557.12M
INR -2.05M -1.24M -62.78M -148.57M 93.53M 312.43M 240.02M 138.25M 201.39M 206.74M
INR -795.77M -809.18M -1.35B -469.3M 255.65M 898.59M 650.49M 475.11M 357.37M 349.04M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 88.19M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.